Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)
- First Posted Date
- 2020-06-26
- Last Posted Date
- 2022-06-06
- Target Recruit Count
- 149
- Registration Number
- NCT04448756
- Locations
- 🇺🇸
Holy Name Hospital - Dept of Multiple Sclerosis Comp Care Center, Teaneck, New Jersey, United States
🇧🇷Hospital Dia do Pulmão, Blumenau, Brazil
🇧🇷Instituto de Infectologia Emílio Ribas, São Paulo, Brazil
Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2023-10-23
- Target Recruit Count
- 146
- Registration Number
- NCT04246489
- Locations
- 🇺🇸
The Stamford Hospital, Stamford, Connecticut, United States
🇺🇸Karmanos Cancer Institute, Farmington Hills, Michigan, United States
🇺🇸Comprehensive Cancer Centers of Nevada, Henderson, Nevada, United States
Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
- Conditions
- Interventions
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2024-11-26
- Target Recruit Count
- 204
- Registration Number
- NCT04170153
- Locations
- 🇯🇵
National Cancer Center Hospital - Dept of Experimental Therapeutics, Chuo-ku, Japan
🇨🇳Beijing Cancer Hospital, Beijing, China
🇪🇸Hospital Universitari Vall d'Hebron - Oncology Dept., Barcelona, Spain
First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2023-03-24
- Target Recruit Count
- 10
- Registration Number
- NCT04075721
- Locations
- 🇺🇸
Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸Georgetown University Medical Center- Research Parent, Washington, District of Columbia, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
- Conditions
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2023-11-14
- Target Recruit Count
- 309
- Registration Number
- NCT04066491
- Locations
- 🇺🇸
Methodist Transplant Physicians, Dallas, Texas, United States
🇺🇸MD Anderson Cancer Center - Unit 429, Houston, Texas, United States
🇺🇸Renovatio Clinical - CENTRAL SITE, The Woodlands, Texas, United States
Study of Evobrutinib in Participants With RMS
- Conditions
- Interventions
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2021-08-05
- Target Recruit Count
- 1
- Registration Number
- NCT04032171
- Locations
- 🇺🇸
Please Contact U.S. Medical Information, Rockland, Massachusetts, United States
🇩🇪Please Contact the Communication Center, Darmstadt, Germany
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
- Conditions
- Interventions
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2021-08-05
- Target Recruit Count
- 3
- Registration Number
- NCT04032158
- Locations
- 🇺🇸
Please Contact U.S. Medical Information, Rockland, Massachusetts, United States
🇩🇪Please Contact the Communication Center, Darmstadt, Germany
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2023-10-31
- Target Recruit Count
- 662
- Registration Number
- NCT03961204
- Locations
- 🇬🇪
S. Khechinashvili University Clinic, Tbilisi, Georgia
🇱🇧Bellevue Medical Center, Beirut, Lebanon
🇦🇹Barmherzige Brueder Konventspital Linz - Abteilung fuer Neurologie, Linz, Austria
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
- Conditions
- Interventions
- First Posted Date
- 2019-05-07
- Last Posted Date
- 2024-12-11
- Target Recruit Count
- 140
- Registration Number
- NCT03940703
- Locations
- 🇺🇸
Community Health Network, Indianapolis, Indiana, United States
🇺🇸Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
🇨🇳The First Affiliated Hospital, Zhejiang University, Hangzhou, China
A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2024-10-09
- Target Recruit Count
- 102
- Registration Number
- NCT03933215
- Locations
- 🇺🇸
VCU Medical Center - Pediatric Neurology, Richmond, Virginia, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸HCA Research Institute, Englewood, Colorado, United States